These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Apixaban Versus Warfarin for Mechanical Heart Valve Thromboprophylaxis in a Swine Aortic Heterotopic Valve Model. Lester PA; Coleman DM; Diaz JA; Jackson TO; Hawley AE; Mathues AR; Grant BT; Knabb RM; Ramacciotti E; Frost CE; Song Y; Wakefield TW; Myers DD Arterioscler Thromb Vasc Biol; 2017 May; 37(5):942-948. PubMed ID: 28232327 [TBL] [Abstract][Full Text] [Related]
6. Short- and long-term efficacy of aspirin and clopidogrel for thromboprophylaxis for mechanical heart valves: an in vivo study in swine. McKellar SH; Thompson JL; Garcia-Rinaldi RF; Macdonald RJ; Sundt TM; Schaff HV J Thorac Cardiovasc Surg; 2008 Oct; 136(4):908-14. PubMed ID: 18954629 [TBL] [Abstract][Full Text] [Related]
8. A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: THE Randomized, phase II study to evaluate the safety and pharmacokinetics of oral dabigatran etexilate in patients after heart valve replacement (RE-ALIGN). Van de Werf F; Brueckmann M; Connolly SJ; Friedman J; Granger CB; Härtter S; Harper R; Kappetein AP; Lehr T; Mack MJ; Noack H; Eikelboom JW Am Heart J; 2012 Jun; 163(6):931-937.e1. PubMed ID: 22709744 [TBL] [Abstract][Full Text] [Related]
9. Thrombosis on a Mechanical Aortic Valve whilst Anti-coagulated With Dabigatran. Stewart RA; Astell H; Young L; White HD Heart Lung Circ; 2012 Jan; 21(1):53-5. PubMed ID: 21937274 [TBL] [Abstract][Full Text] [Related]
10. Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*). A randomised, double-blind, non-inferiority trial. Eriksson BI; Dahl OE; Huo MH; Kurth AA; Hantel S; Hermansson K; Schnee JM; Friedman RJ; Thromb Haemost; 2011 Apr; 105(4):721-9. PubMed ID: 21225098 [TBL] [Abstract][Full Text] [Related]
11. A model of heterotopic aortic valve replacement for studying thromboembolism prophylaxis in mechanical valve prostheses. McKellar SH; Thompson JL; Schaff HV J Surg Res; 2007 Jul; 141(1):1-6. PubMed ID: 17512549 [TBL] [Abstract][Full Text] [Related]
12. Non-Vitamin K Antagonist Oral Anticoagulants for Mechanical Heart Valves: Is the Door Still Open? Aimo A; Giugliano RP; De Caterina R Circulation; 2018 Sep; 138(13):1356-1365. PubMed ID: 30354416 [TBL] [Abstract][Full Text] [Related]
13. Dabigatran: new drug. Continue to use heparin, a better-known option. Prescrire Int; 2009 Jun; 18(101):97-9. PubMed ID: 19637411 [TBL] [Abstract][Full Text] [Related]
14. Dabigatran etexilate: pivotal trials for venous thromboembolism prophylaxis after hip or knee arthroplasty. Eriksson BI; Friedman RJ Clin Appl Thromb Hemost; 2009; 15 Suppl 1():25S-31S. PubMed ID: 19648146 [TBL] [Abstract][Full Text] [Related]
15. Dabigatran etexilate: an oral direct thrombin inhibitor for prophylaxis and treatment of thromboembolic diseases. Baetz BE; Spinler SA Pharmacotherapy; 2008 Nov; 28(11):1354-73. PubMed ID: 18956996 [TBL] [Abstract][Full Text] [Related]
16. Melagatran for thromboprophylaxis after mechanical valve implantation: results in a heterotopic porcine model. Thompson JL; Hamner CE; Potter DD; Lewin M; Sundt TM; Schaff HV J Thorac Cardiovasc Surg; 2007 Aug; 134(2):359-65. PubMed ID: 17662773 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of delayed thromboprophylaxis with dabigatran: pooled analysis. Eriksson BI; Dahl OE; Rosencher N; Clemens A; Hantel S; Kurth AA Thromb Res; 2012 Dec; 130(6):871-6. PubMed ID: 22995531 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplasty. A meta-analysis. Wolowacz SE; Roskell NS; Plumb JM; Caprini JA; Eriksson BI Thromb Haemost; 2009 Jan; 101(1):77-85. PubMed ID: 19132192 [TBL] [Abstract][Full Text] [Related]